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Purpose: To test the hypothesis that in dark-adapted diabetic mice subnormal manganese uptake in the outer retina can
be ameliorated with exogenous 11-cis-retinal intervention.
Methods: Three groups were studied: age-matched controls and mice that had been diabetic for 3 months with and without
acute, systemic 11-cis-retinal treatment administered 30 min before the manganese injection. Mice in each group were
examined with manganese-enhanced magnetic resonance imaging (MEMRI) to assess central intraretinal manganese
uptake and extraocular muscle manganese uptake. Bodyweights and glycated hemoglobin were determined.
Results: Both diabetic groups had lower bodyweights and higher glycated hemoglobin levels relative to controls; no
differences in these parameters between diabetic groups were noted. No substantial differences in muscle uptake were
noted between any of the groups. Diabetes produced a subnormal intraretinal uptake of manganese; acute exogenous 11-
cis-retinal significantly corrected only outer retinal uptake, although not to control levels.
Conclusions: The present results provide for the first time evidence that raises the possibility of a critical role of 11-cis-
retinal, a key participant of the visual cycle, in diabetes-evoked outer retinal dysfunction.
Vision begins in the photoreceptors. In the dark, healthy
rod photoreceptor membranes are primarily depolarized via
open  cyclic  guanosine  monophosphate  (cGMP)-gated  ion
channels. In the light, rhodopsin (which consists of opsin and
covalently  bound  11-cis-retinal)  undergoes  a  cis-to-trans
isomerization. Through a series of signal transduction steps,
this isomerization normally results in closure of rod cGMP
channels and hyperpolarization of rod membranes. However,
in  non-diabetic  mouse  models  of  visual  cycle  disease,
regeneration  of  rhodopsin,  due,  for  example,  to  reduced
availability  of  11-cis-retinal,  is  impaired  leading  to  the
following sequential chain of events: a persistent buildup of
unbound opsin, cGMP hydrolysis, closure of ion channels,
and  chronic  hyperpolarization  of  the  photoreceptor
membranes even in the dark [1]. Importantly, systemic 11-
cis-retinal administration is effective at relieving such visual
cycle lesions and maintaining photoreceptor membranes in a
depolarized (i.e., open) state in the dark, consistent with the
generation of sufficient rhodopsin to relieve opsin buildup and
decrease cGMP hydrolysis [2].
Diabetic retinopathy, the leading cause of vision loss and
blindness in patients under the age of 65 years old, is clinically
considered a vascular disease. However, there is mounting
evidence of neural retinal dysfunction before the appearance
of vascular lesions [3–7]. Intriguingly, diabetes imparts overt
retinal microvessel histopathology but largely leaves brain
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blood vessels unharmed [8]. This discrepancy between retinal
and brain responses to diabetes has focused attention on a
unique  aspect  of  the  retina  compared  to  the  brain:  the
photoreceptors. Patients can present with sensory neuronal
pathophysiology  linked  with  alterations  in  key  aspects  of
vision including impaired dark adaptation [7,9]. Furthermore,
focal changes in neuronal retinal function predict the onset of
diabetic retinopathy with a sensitivity of 80% and a specificity
of 74% [6,10]. To date, fundamental knowledge gaps exist
with  regard  to  how  layer-specific  neuroretinal  lesions  are
produced by diabetes. Correlations have been found between
diabetes and subnormal rhodopsin generation, reductions in
the expression of genes involved with the phototransduction
pathway, and with visual cycle protein levels [11–14]. These
results suggest but do not prove the presence of visual cycle
lesions  in  diabetic  retinopathy.  One  approach  to  directly
testing this idea is to intervene with 11-cis-retinal (a drug
targeted to visual cycle defects) and determine if outer retinal
ion dysfunction improves.
Previously, we demonstrated that genetically-induced,
impaired  11-cis-retinal  production  in  mice  produced  an
abnormal outer retinal ion channel closure on manganese-
enhanced magnetic resonance imaging (MEMRI) and that
acute, exogenous 11-cis-retinal corrected this lesion [2]. In the
present study, we asked the question: would acute treatment
of dark-adapted diabetic mice with systemic 11-cis-retinal
alter inner and outer retinal ion channel status as interrogated
non-invasively with MEMRI? The results from the present
experiments  demonstrate  that  diabetes-evoked  abnormal
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372outer retinal ion channel closure can be significantly, if partly,
improved with acute exogenous 11-cis-retinal.
METHODS
All animals were treated in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals,  the  Association  for  Research  in  Vision  and
Ophthalmology  Statement  for  the  Use  of  Animals  in
Ophthalmic and Vision Research, and Institutional Animal
and Care Use Committee authorization. Animals were housed
and maintained in normal 12 h:12 light-dark cycle laboratory
lighting, unless otherwise noted.
Groups: MEMRI was used to study different groups of
male C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME):
control group (wild type (WT); n=9, weight range 30–36 g,
age about 5 months), diabetic group (D; n=9, weight range
17–23 g, age about 5 months, diabetic for 3 months), and
diabetic + 11-cis-retinal group (D+11cis; n=10, weight range
20−25 g, age about 5 months, diabetic for 3 months). 11-cis-
retinal (approximately 25 mg/kg mouse), obtained through an
NEI program, was constituted in a 10% ethanol and phosphate
buffered  saline  and  BSA  solution,  and  administered  as  a
0.01  ml/g  bolus  intraperitoneal  [15]  30  min  before  the
manganese injection (see below).
Diabetes was induced in mice with starting weights of 16
to 20 g by streptozotocin (60 mg/kg; 10 mM citrate buffer [pH
4.5]) intraperitoneal injection once a day for 5 consecutive
days. Bodyweight and blood glucose levels were monitored
twice  weekly.  Insulin  (neutral  protamine  Hagedorn),
administered to mice as needed based on bodyweight and
blood glucose levels but not more than twice weekly, allowed
slow weight gain while maintaining hyperglycemia (blood
glucose levels higher than 400 mg/dl). Mice that lost weight
and/or had blood glucose levels greater than 600 mg/dl were
given 0.2 units of Lilly Humulin N insulin. Normal rodent
chow (Purina TestDiet 5001; Richmond, IN, which contains
11.2% fat, 26% protein and 62.7% carbohydrate) and water
were  provided  ad  libitum.  Glycated  hemoglobin  was
measured from blood collected after each MEMRI experiment
(Glyco-Tek affinity columns, kit 5351; Helena Laboratories,
Beaumont, TX). Blood was drawn from the left ventricle, after
puncture, into a capillary tube and stored in an eppendorf tube
with a small amount of heparin to prevent coagulation. The
blood was kept in the refrigerator until analysis within one
week following the MEMRI experiment.
Outcome measures: The methodologies for measuring
MEMRI parameters have been described in detail previously
[3]. Briefly, for MEMRI, all mice were maintained in darkness
for 16 to 20 h before manganese injection. All procedures
(e.g., weighing, injecting 11-cis-retinal and MnCl2, anesthetic
administration,  and  magnetic  resonance  imaging  [MRI]
examination) were performed under dim red light or darkness.
MnCl2  was  administered  as  an  intraperitoneal  injection
(66  mg/kg)  on  the  right  side  of  awake  mice.  After  this
injection, mice were maintained in dark conditions for another
3.5 to 4 h. Immediately before the MRI experiment, mice were
anesthetized with urethane (36% solution intraperitoneally;
0.083 ml/20 g animal weight, prepared fresh daily; Aldrich,
Milwaukee, WI). MRI data were acquired on a 7T system
(Clinscan; Bruker, Billeric, MA). Retinal partial saturation
T1 data were acquired using a dual coil mode on a 7 T Bruker
Clinscan system: Several single spin-echo (time to echo [TE]
13 ms, matrix size 160×320, slice thickness 600 μm) images
were  acquired  at  different  repetition  times  [TRs]  in  the
following  order  (number  per  time  between  repetitions  in
parentheses): TR 0.15 s (6), 3.50 s (1), 1.00 s (2), 1.90 s (1),
0.35 s (4), 2.70 s (1), 0.25 s (5), and 0.50 s (3). To compensate
for reduced signal-noise ratios at shorter TRs, progressively
more images were collected as the TR decreased. After the
MEMRI examination, a final blood sample was obtained for
glycated hemoglobin analysis, and the mice were humanely
euthanatized.
Data  analysis:  MEMRI  data  of  central  retinal  data
(±1 mm from the center of the optic nerve, see Figure 1A)
were analyzed as follows: single images acquired with the
same TR were first registered (rigid body) and then averaged.
These averaged images were then registered across TRs. The
same  regions-of-interest  as  above  were  analyzed  by
calculating 1/T1 maps by first fitting to a three-parameter T1
equation (y=a + b*(exp(-c*TR)), where a, b, and c are fitted
parameters)  on  a  pixel-by-pixel  basis  using  R  (v.2.9.0,  R
Development  Core  Team  [2009]).  R:  A  language  and
environment  for  statistical  computing.  R  Foundation  for
Statistical Computing, Vienna, Austria. ISBN 3–900051–07–
0) scripts developed in-house, and the minpack.lm package
(v.1.1.1,  Timur  V.  Elzhov  and  Katharine  M.  Mullen
minpack.lm:  R  interface  to  the  Levenberg-Marquardt
nonlinear  least-squares  algorithm  found  in  MINPACK.  R
package version 1.1–1.). The reciprocal (1/T1) values directly
reflect manganese levels [16]. On 1/T1 parameter maps, the
inner and outer retinal division is observable in dark-adapted
retinas, and pixels immediately anterior and posterior to this
division were extracted as follows. On relaxation rate (1/T1)
maps of dark adapted retina, the inner/outer retina division
was  observable  (based  on  contrast  generated  by  the
differential amount of manganese taken up in inner and outer
retina on these maps). We measured relaxation rates from one
pixel layer located anterior and posterior of this division to
sample inner and outer retina, respectively. In addition, central
intraretinal 1/T1 profiles were examined in each mouse to
ensure that the choice of inner / outer retinal division was
appropriate and that the representative inner and outer retinal
values were reasonable [17]. The 1/T1 of the same extraocular
muscle group was measured in all groups to compare systemic
handling of the injected manganese.
Note that only those animals that took up manganese
above baseline (0.65 s−1) were included in the final analysis
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373of  retinal  and  extraocular  muscle.  In  addition,  the  same
extraocular muscle region-of-interest was either not present
(i.e., out of slice) or was difficult to discern for some animals.
For these reasons, note that the numbers of animals used in
each measure were somewhat different.
Statistical  analysis:  Comparisons  of  MEMRI  retinal
signal  intensities  were  performed  using  a  generalized
estimating equation (GEE) approach [17,18]. GEE performs
a general linear regression analysis using all of the pixels in
each subject and accounts for the within-subject correlation
between  adjacent  pixels.  GEE  was  performed  using  the
GENMOD procedure in SAS for Windows with the working
correlation  matrix  set  to  autoregressive  [1]  and  the  scale
parameter set to the Pearson  χ2. The MEMRI extraocular
muscle 1/T1 data, measured from a single region-of-interest
and  thus  not  subject  to  correlations  between  pixels,  was
consistent with a normal distribution and data analyzed with
a  two-tailed  t  test.  In  all  cases,  two-tailed  p<0.05  was
considered statistically significant.
RESULTS
Systemic physiology: In this study, control mice bodyweights
were 32.8±0.5 g (mean±SEM), and the glycated hemoglobin
levels  were  5.9±0.2%.  Untreated  diabetic  mice  had
bodyweights of 19.3±0.9 g, and glycated hemoglobin levels
of  13.2±0.5%.  The  11-cis-retinal-treated  diabetic  mice
bodyweights were 22.5±0.6 g, and their glycated hemoglobin
levels were 12.9±0.3%. The difference in bodyweights and
glycated  hemoglobin  levels  were  statistically  different
between diabetic mice and control mice (p<0.05), and there
were no differences in bodyweight or glycated hemoglobin
levels between treated and untreated diabetic groups.
Manganese-enhanced  magnetic  resonance  imaging:
Extraocular uptake of manganese, an indicator of systemic
loading  of  the  injected  manganese,  was  not  statistically
different (p>0.05) between the controls (n=6, 1.10±0.07 s−1,
range 0.9–1.3 s−1), untreated diabetics (n=7, 1.02±0.06 s−1,
0.8–1.2 s−1), and treated diabetics (n=8, 1.10±0.03 s−1, 0.9–1.2
s−1).  This  demonstrates  similar  uptake  and  delivery  of
manganese in all groups.
Qualitative inspection of 1/T1 parameter maps suggested
that diabetic mice had reduced uptake from controls, and that
11-cis-retinal treatment of diabetic mice partially restored
central retinal uptake of manganese (Figure 1A). Quantitative
analysis (Figure 1), demonstrated that the untreated mice that
Figure 1. The inner and outer retina of
diabetic mice take up less manganese
than  in  controls  –  a  pattern  partially
corrected  in  the  outer  retina  upon
treatment  with  11-cis-retinal.  A:
Representative  pseudo-color  spin-
lattice relaxation rate (1/T1) parameter
maps of control (left), diabetic (middle),
and diabetic treated with 11-cis-retinal
(right) mice illustrate lower uptake in
diabetics, and partial correction with 11-
cis-retinal  treatment.  Note  that  1/T1
values directly reflect manganese levels
[16] and greater manganese uptake is
indicated by brighter retinal reds. The
central retinal regions analyzed in this
study are indicated by the white boxes
and the extraocular muscle region-of-
interest analyzed herein is illustrated in
the  right-most  image.  B:  Quantitative
analysis of manganese uptake in inner
(left graph) and outer retina (right graph)
confirms the pattern suggested by the
representative images above. * indicates
a significant difference (p<0.05) from
control  mice  values;  #  indicates  a
significant difference (p<0.05) from the
diabetic  mice  values.  The  error  bars
represent  standard  deviations,  and
numbers above the bars represent the
number of animals studied.
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374had  been  diabetic  for  3  months  had  significantly  lower
manganese uptake in the inner and outer retina (66% and 53%
of control, respectively; calculated after subtracting baseline
1/T1 of 0.65 s−1). Diabetic animals treated acutely with 11-
cis-retinal maintained (p>0.05) reduced inner retinal uptake,
but outer retinal manganese uptake was increased (p<0.05) to
23% of control (Figure 1B).
DISCUSSION
In this study, in dark-adapted diabetic mice in vivo, 11-cis-
retinal treatment significantly, but partially, improved outer
retinal manganese uptake without a discernable benefit on
uptake in the inner retina. This is consistent with the highly
selective role of 11-cis-retinal in the outer retina as the key
light-sensing  chromophore.  Group  differences  in  systemic
handling  of  the  injected  manganese  do  not  explain  the
variations  in  intraretinal  uptake  patterns  because  of  the
distinct intraretinal patterns noted above and the similar extent
of muscle uptake between groups. Although 11-cis-retinal
uptake, transport, and storage are complicated [19], and may
be impaired by diabetes, the present results support some
benefit  of  11-cis-retinal  supplementation  on  manganese-
permeable outer retinal ion channels in a manner consistent
with visual cycle biology [2]. We based the timing of the
present studies on our previous work in rd12 mice in which 4
h between 11-cis-retinal injection and MEMRI examination
was  adequate  for  documenting  effective  opening  of  outer
retinal ion channels, even though all of the 11-cis-retinal was
not likely to be available at this time [2,19]. Future studies are
needed to determine if higher doses or longer duration of
treatment  with  11-cis-retinal  would  be  more  effective  at
further improving outer retinal function [19]. To further probe
the molecular mechanisms underlying how exogenous 11-
cis-retinal opened outer retinal ion channels, future studies
will  measure  retinal  levels  of  11-cis-retinal  or  11-trans-
retinal, as well as systemic vitamin A levels [20]. Nonetheless,
the present results raise the possibility, for the first time, of a
critical contribution of 11-cis-retinal to a diabetes-produced
outer retinal lesion in vivo.
MEMRI non-invasively measures, in continuously dark-
adapted awake and freely moving mice, a history of neuronal
activity  based  on  the  extent  of  retinal  layer-specific
accumulation of a calcium ion surrogate, manganese ion [4,
17,21]. Importantly, the MEMRI-related procedures require
little to no light, and this greatly facilitates evaluating the
efficacy  of  11-cis-retinal,  an  extremely  light-labile
compound.
Previously, we found that preventing oxidative stress in
diabetic  mice  or  rats  corrected  the  subnormal  intraretinal
uptake  on  MEMRI  [3,4].  Intriguingly,  Anderson  et  al.
reported that elevated oxidative stress per se could reduce how
much rhodopsin is regenerated from exogenously added 11-
cis-retinal  by  40%–50%;  our  present  results  also  found  a
partial  benefit  on  outer  retinal  channels  (consistent  with
partial rhodopsin regeneration from exogenous 11-cis-retinal)
[22]. It is not yet clear how retinal oxidative stress (due to
diabetes)  and  rhodopsin  regeneration  are  mechanistically
linked. One suggestion is that diabetes induces a more acidic
condition within the rod photoreceptors that causes a delay in
rhodopsin  regeneration  [23].  However,  direct  pH
measurements in diabetic animals did not seem to support this
notion [24,25]. Diabetes clearly alters mitochondrial function,
and this could reduce the energy available for keeping the
cGMP channels open in the dark [26,27]. The present results
might not support this idea: 11-cis-retinal supplementation
partly  restored  manganese  uptake  indicating  that  enough
energy was available to maintain open channels, at least to
some degree. These data are consistent with our previous
finding that retinal ATP levels are similar between diabetic
and controls [28]. Alternatively, it is possible that oxidative
stress alters, for example, RPE65 activity and thus reduces 11-
cis-retinal  synthesis  in  diabetic  mice.  Oxidative  stress  is
reported to cleave RPE65 in retinal pigment epithelium cells
although the functional significance of the cleavage product
is unknown [29]. In addition, systemic vitamin A may have
been  generally  less  available  to  the  diabetic  retina  [20].
Although additional future studies are needed to address the
above  possibilities,  regardless  of  mechanism,  the  present
findings  are  consistent  with  acute,  systemic  11-cis-retinal
treatment at least partly improving a key aspect of a visual
cycle lesion in the diabetic mouse model.
The results of this study, and the above considerations,
provide for the first time evidence supporting a role of 11-
cis-retinal in a diabetes-evoked functional defect specifically
in the outer retina in vivo.
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